Mark Wessels

7PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesNeurosciences not elsewhere classifiedCellular nervous systemPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 14, 2026
Survivor bias and disease progression in observational cohorts in multiple sclerosis.

|Jul 23, 2025
Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS).

W H Fung, M H J Wessels, E M E Coerver

|Jun 12, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.

Ahmed Abdelhak, Franziska Bachhuber, Kiarra Ning

|Nov 04, 2024
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients.

Alyssa A Toorop, Mark Hj Wessels, Lynn Boonkamp

|Oct 18, 2024
Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic.

Zoë Ygj van Lierop, Mark Hj Wessels, Womei Ml Lekranty

|Aug 02, 2023
Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.

Mark Hj Wessels, Zoë Ygj Van Lierop, Samantha Noteboom

Pageof 2

Frequent Collaborators

5 joint publications

Eva Mm Strijbis

3 joint publications

Zoë Ygj Van Lierop

3 joint publications

Zoé LE Van Kempen

2 joint publications

Menno M Schoonheim